Do analysts prefer BNR or AUNA?

Auna has a consensus price target of $6.97, suggesting a potential upside of 35.93%. Given Auna's stronger consensus rating and higher possible upside, analysts plainly believe Auna is more favorable than Burning Rock Biotech. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Burning Rock Biotech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Auna 1 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.40

Do analysts rate BNR or SBC?

SBC Medical Group has a consensus price target of $8.50, suggesting a potential upside of 175.97%. Given SBC Medical Group's stronger consensus rating and higher probable upside, analysts plainly believe SBC Medical Group is more favorable than Burning Rock Biotech. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Burning Rock Biotech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 SBC Medical Group 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33

Do analysts prefer AIRS or BNR?

AirSculpt Technologies currently has a consensus target price of $4.50, indicating a potential upside of 1.12%. Given AirSculpt Technologies' stronger consensus rating and higher probable upside, analysts clearly believe AirSculpt Technologies is more favorable than Burning Rock Biotech. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AirSculpt Technologies 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Burning Rock Biotech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts prefer LFMD or BNR?

LifeMD currently has a consensus target price of $9.14, suggesting a potential upside of 120.31%. Given LifeMD's stronger consensus rating and higher probable upside, research analysts clearly believe LifeMD is more favorable than Burning Rock Biotech. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LifeMD 1 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.70 Burning Rock Biotech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts rate BDSX or BNR?

Biodesix presently has a consensus price target of $28.33, indicating a potential upside of 40.33%. Given Biodesix's stronger consensus rating and higher possible upside, analysts plainly believe Biodesix is more favorable than Burning Rock Biotech. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biodesix 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 2.80 Burning Rock Biotech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Burning Rock Biotech (BNR) Competitors

$9.97 +0.37 (+3.85%)

Closing price 03:59 PM Eastern

Extended Trading

$9.78 -0.19 (-1.86%)

As of 04:10 PM Eastern

Compare

BNR vs. AUNA, SBC, AIRS, LFMD, and BDSX

Should you buy Burning Rock Biotech stock or one of its competitors? MarketBeat compares Burning Rock Biotech with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Burning Rock Biotech include Auna (AUNA), SBC Medical Group (SBC), AirSculpt Technologies (AIRS), LifeMD (LFMD), and Biodesix (BDSX). These companies are all part of the "healthcare" industry.

How does Burning Rock Biotech compare to Auna?

Burning Rock Biotech (NASDAQ:BNR) and Auna (NYSE:AUNA) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, earnings, profitability, institutional ownership, dividends and risk.

30.0% of Burning Rock Biotech shares are owned by institutional investors. 30.3% of Burning Rock Biotech shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Auna has a consensus price target of $6.97, suggesting a potential upside of 35.93%. Given Auna's stronger consensus rating and higher possible upside, analysts plainly believe Auna is more favorable than Burning Rock Biotech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Burning Rock Biotech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Auna	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.40

Burning Rock Biotech has a beta of 1.32, suggesting that its stock price is 32% more volatile than the broader market. Comparatively, Auna has a beta of 0.62, suggesting that its stock price is 38% less volatile than the broader market.

Auna has a net margin of 1.53% compared to Burning Rock Biotech's net margin of -11.57%. Auna's return on equity of 16.25% beat Burning Rock Biotech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Burning Rock Biotech	-11.57%	-10.98%	-7.33%
Auna	1.53%	16.25%	4.03%

Auna has higher revenue and earnings than Burning Rock Biotech. Burning Rock Biotech is trading at a lower price-to-earnings ratio than Auna, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Burning Rock Biotech	$77.16M	1.36	-$7.92M	-$0.82	N/A
Auna	$1.23B	0.31	$27.39M	$0.26	19.71

In the previous week, Auna had 2 more articles in the media than Burning Rock Biotech. MarketBeat recorded 2 mentions for Auna and 0 mentions for Burning Rock Biotech. Burning Rock Biotech's average media sentiment score of 0.94 beat Auna's score of 0.00 indicating that Burning Rock Biotech is being referred to more favorably in the media.

Company	Overall Sentiment
Burning Rock Biotech	Positive
Auna	Neutral

Summary

Auna beats Burning Rock Biotech on 12 of the 17 factors compared between the two stocks.

How does Burning Rock Biotech compare to SBC Medical Group?

Burning Rock Biotech (NASDAQ:BNR) and SBC Medical Group (NASDAQ:SBC) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, earnings, risk, analyst recommendations, valuation and institutional ownership.

Burning Rock Biotech has a beta of 1.32, suggesting that its stock price is 32% more volatile than the broader market. Comparatively, SBC Medical Group has a beta of 0.6, suggesting that its stock price is 40% less volatile than the broader market.

In the previous week, SBC Medical Group had 3 more articles in the media than Burning Rock Biotech. MarketBeat recorded 3 mentions for SBC Medical Group and 0 mentions for Burning Rock Biotech. Burning Rock Biotech's average media sentiment score of 0.94 beat SBC Medical Group's score of 0.76 indicating that Burning Rock Biotech is being referred to more favorably in the media.

Company	Overall Sentiment
Burning Rock Biotech	Positive
SBC Medical Group	Positive

30.0% of Burning Rock Biotech shares are held by institutional investors. Comparatively, 60.8% of SBC Medical Group shares are held by institutional investors. 30.3% of Burning Rock Biotech shares are held by insiders. Comparatively, 81.7% of SBC Medical Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

SBC Medical Group has a consensus price target of $8.50, suggesting a potential upside of 175.97%. Given SBC Medical Group's stronger consensus rating and higher probable upside, analysts plainly believe SBC Medical Group is more favorable than Burning Rock Biotech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Burning Rock Biotech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
SBC Medical Group	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

SBC Medical Group has higher revenue and earnings than Burning Rock Biotech. Burning Rock Biotech is trading at a lower price-to-earnings ratio than SBC Medical Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Burning Rock Biotech	$77.16M	1.36	-$7.92M	-$0.82	N/A
SBC Medical Group	$173.61M	1.82	$50.99M	$0.39	7.90

SBC Medical Group has a net margin of 24.09% compared to Burning Rock Biotech's net margin of -11.57%. SBC Medical Group's return on equity of 15.90% beat Burning Rock Biotech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Burning Rock Biotech	-11.57%	-10.98%	-7.33%
SBC Medical Group	24.09%	15.90%	11.61%

Summary

SBC Medical Group beats Burning Rock Biotech on 14 of the 16 factors compared between the two stocks.

How does Burning Rock Biotech compare to AirSculpt Technologies?

AirSculpt Technologies (NASDAQ:AIRS) and Burning Rock Biotech (NASDAQ:BNR) are both small-cap business services companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, profitability, institutional ownership, analyst recommendations, valuation, dividends, media sentiment and risk.

AirSculpt Technologies has a beta of 2.34, indicating that its stock price is 134% more volatile than the broader market. Comparatively, Burning Rock Biotech has a beta of 1.32, indicating that its stock price is 32% more volatile than the broader market.

Burning Rock Biotech has lower revenue, but higher earnings than AirSculpt Technologies. AirSculpt Technologies is trading at a lower price-to-earnings ratio than Burning Rock Biotech, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AirSculpt Technologies	$151.82M	2.07	-$11.67M	-$0.17	N/A
Burning Rock Biotech	$77.16M	1.36	-$7.92M	-$0.82	N/A

AirSculpt Technologies currently has a consensus target price of $4.50, indicating a potential upside of 1.12%. Given AirSculpt Technologies' stronger consensus rating and higher probable upside, analysts clearly believe AirSculpt Technologies is more favorable than Burning Rock Biotech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AirSculpt Technologies	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Burning Rock Biotech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

91.5% of AirSculpt Technologies shares are owned by institutional investors. Comparatively, 30.0% of Burning Rock Biotech shares are owned by institutional investors. 44.6% of AirSculpt Technologies shares are owned by insiders. Comparatively, 30.3% of Burning Rock Biotech shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

AirSculpt Technologies has a net margin of -7.39% compared to Burning Rock Biotech's net margin of -11.57%. AirSculpt Technologies' return on equity of -4.98% beat Burning Rock Biotech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AirSculpt Technologies	-7.39%	-4.98%	-2.36%
Burning Rock Biotech	-11.57%	-10.98%	-7.33%

In the previous week, AirSculpt Technologies' average media sentiment score of 1.87 beat Burning Rock Biotech's score of 0.94 indicating that AirSculpt Technologies is being referred to more favorably in the media.

Company	Overall Sentiment
AirSculpt Technologies	Very Positive
Burning Rock Biotech	Positive

Summary

AirSculpt Technologies beats Burning Rock Biotech on 12 of the 14 factors compared between the two stocks.

How does Burning Rock Biotech compare to LifeMD?

LifeMD (NASDAQ:LFMD) and Burning Rock Biotech (NASDAQ:BNR) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, risk, profitability, institutional ownership, analyst recommendations and media sentiment.

LifeMD has a net margin of 2.37% compared to Burning Rock Biotech's net margin of -11.57%. Burning Rock Biotech's return on equity of -10.98% beat LifeMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LifeMD	2.37%	-150.88%	-22.59%
Burning Rock Biotech	-11.57%	-10.98%	-7.33%

In the previous week, LifeMD had 1 more articles in the media than Burning Rock Biotech. MarketBeat recorded 1 mentions for LifeMD and 0 mentions for Burning Rock Biotech. LifeMD's average media sentiment score of 1.49 beat Burning Rock Biotech's score of 0.94 indicating that LifeMD is being referred to more favorably in the media.

Company	Overall Sentiment
LifeMD	Positive
Burning Rock Biotech	Positive

LifeMD currently has a consensus target price of $9.14, suggesting a potential upside of 120.31%. Given LifeMD's stronger consensus rating and higher probable upside, research analysts clearly believe LifeMD is more favorable than Burning Rock Biotech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LifeMD	1 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.70
Burning Rock Biotech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

LifeMD has higher revenue and earnings than Burning Rock Biotech. Burning Rock Biotech is trading at a lower price-to-earnings ratio than LifeMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LifeMD	$194.05M	1.03	$14.35M	$0.05	83.00
Burning Rock Biotech	$77.16M	1.36	-$7.92M	-$0.82	N/A

LifeMD has a beta of 1.99, suggesting that its stock price is 99% more volatile than the broader market. Comparatively, Burning Rock Biotech has a beta of 1.32, suggesting that its stock price is 32% more volatile than the broader market.

35.5% of LifeMD shares are owned by institutional investors. Comparatively, 30.0% of Burning Rock Biotech shares are owned by institutional investors. 17.2% of LifeMD shares are owned by insiders. Comparatively, 30.3% of Burning Rock Biotech shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

LifeMD beats Burning Rock Biotech on 12 of the 16 factors compared between the two stocks.

How does Burning Rock Biotech compare to Biodesix?

Biodesix (NASDAQ:BDSX) and Burning Rock Biotech (NASDAQ:BNR) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, media sentiment, earnings, institutional ownership, risk, profitability and valuation.

Burning Rock Biotech has lower revenue, but higher earnings than Biodesix. Burning Rock Biotech is trading at a lower price-to-earnings ratio than Biodesix, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biodesix	$88.50M	2.36	-$35.26M	-$4.06	N/A
Burning Rock Biotech	$77.16M	1.36	-$7.92M	-$0.82	N/A

21.0% of Biodesix shares are owned by institutional investors. Comparatively, 30.0% of Burning Rock Biotech shares are owned by institutional investors. 23.2% of Biodesix shares are owned by company insiders. Comparatively, 30.3% of Burning Rock Biotech shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Biodesix has a beta of 0.53, indicating that its share price is 47% less volatile than the broader market. Comparatively, Burning Rock Biotech has a beta of 1.32, indicating that its share price is 32% more volatile than the broader market.

Burning Rock Biotech has a net margin of -11.57% compared to Biodesix's net margin of -33.26%. Burning Rock Biotech's return on equity of -10.98% beat Biodesix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biodesix	-33.26%	-2,101.40%	-35.65%
Burning Rock Biotech	-11.57%	-10.98%	-7.33%

Biodesix presently has a consensus price target of $28.33, indicating a potential upside of 40.33%. Given Biodesix's stronger consensus rating and higher possible upside, analysts plainly believe Biodesix is more favorable than Burning Rock Biotech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biodesix	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.80
Burning Rock Biotech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Biodesix's average media sentiment score of 1.87 beat Burning Rock Biotech's score of 0.94 indicating that Biodesix is being referred to more favorably in the media.

Company	Overall Sentiment
Biodesix	Very Positive
Burning Rock Biotech	Positive

Summary

Biodesix and Burning Rock Biotech tied by winning 8 of the 16 factors compared between the two stocks.

Get Burning Rock Biotech News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BNR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BNR vs. The Competition

Export

Metric	Burning Rock Biotech	Technology Services Industry	Business Sector	NASDAQ Exchange
Market Cap	$101.03M	$3.57B	$6.87B	$12.43B
Dividend Yield	N/A	2.16%	3.03%	8.84%
P/E Ratio	-12.16	33.31	28.54	23.89
Price / Sales	1.36	42.27	349.46	92.07
Price / Cash	N/A	34.26	22.94	60.07
Price / Book	1.37	3.96	5.63	6.18
Net Income	-$7.92M	$31.76M	$203.59M	$331.73M
7 Day Performance	-11.77%	-5.53%	-2.20%	-2.29%
1 Month Performance	41.62%	-9.38%	-2.80%	-1.62%
1 Year Performance	116.27%	-4.50%	9.89%	16.81%

Burning Rock Biotech Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BNR Burning Rock Biotech	1.1479 of 5 stars	$9.97 +3.9%	N/A	+110.5%	$101.03M	$77.16M	N/A	1,390	Positive News Gap Up
AUNA Auna	4.7509 of 5 stars	$5.08 -3.3%	$6.97 +37.3%	-19.3%	$388.57M	$1.23B	19.52	15,254	News Coverage
SBC SBC Medical Group	3.6298 of 5 stars	$3.09 -0.3%	$8.50 +175.1%	-39.5%	$317.99M	$173.61M	7.92	N/A
AIRS AirSculpt Technologies	1.2001 of 5 stars	$4.20 flat	$4.50 +7.1%	-23.0%	$296.29M	$151.82M	N/A	240	Positive News
LFMD LifeMD	2.9389 of 5 stars	$4.51 -5.3%	$9.14 +102.7%	-60.2%	$230.21M	$194.05M	90.22	230	News Coverage Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:BNR) was last updated on 7/17/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Burning Rock Biotech (BNR) Competitors

BNR vs. AUNA, SBC, AIRS, LFMD, and BDSX

How does Burning Rock Biotech compare to Auna?

Summary

How does Burning Rock Biotech compare to SBC Medical Group?

Summary

How does Burning Rock Biotech compare to AirSculpt Technologies?

Summary

How does Burning Rock Biotech compare to LifeMD?

Summary

How does Burning Rock Biotech compare to Biodesix?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BNR vs. The Competition

Burning Rock Biotech Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Burning Rock Biotech (BNR) Competitors

BNR vs. AUNA, SBC, AIRS, LFMD, and BDSX

How does Burning Rock Biotech compare to Auna?

Do insiders and institutionals hold more shares of BNR or AUNA?

Do analysts prefer BNR or AUNA?

Which has more volatility and risk, BNR or AUNA?

Is BNR or AUNA more profitable?

Which has higher valuation and earnings, BNR or AUNA?

Does the media favor BNR or AUNA?

Summary

How does Burning Rock Biotech compare to SBC Medical Group?

Which has more risk and volatility, BNR or SBC?

Does the media favor BNR or SBC?

Do insiders and institutionals have more ownership in BNR or SBC?

Do analysts rate BNR or SBC?

Which has better valuation & earnings, BNR or SBC?

Is BNR or SBC more profitable?

Summary

How does Burning Rock Biotech compare to AirSculpt Technologies?

Which has more risk and volatility, AIRS or BNR?

Which has stronger valuation and earnings, AIRS or BNR?

Do analysts prefer AIRS or BNR?

Do insiders & institutionals believe in AIRS or BNR?

Is AIRS or BNR more profitable?

Does the media refer more to AIRS or BNR?

Summary

How does Burning Rock Biotech compare to LifeMD?

Is LFMD or BNR more profitable?

Does the media prefer LFMD or BNR?

Do analysts prefer LFMD or BNR?

Which has stronger valuation & earnings, LFMD or BNR?

Which has more volatility and risk, LFMD or BNR?

Do insiders and institutionals hold more shares of LFMD or BNR?

Summary

How does Burning Rock Biotech compare to Biodesix?

Which has preferable valuation and earnings, BDSX or BNR?

Do institutionals and insiders believe in BDSX or BNR?

Which has more volatility & risk, BDSX or BNR?

Is BDSX or BNR more profitable?

Do analysts rate BDSX or BNR?

Does the media refer more to BDSX or BNR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BNR vs. The Competition

Burning Rock Biotech Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools